The effective management of radiation-induced bowel injury: a randomised controlled trial

ISRCTN ISRCTN22890916
DOI https://doi.org/10.1186/ISRCTN22890916
Secondary identifying numbers N0258191022
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
29/03/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

http://www.cancerhelp.org.uk/trials/a-study-to-improve-treatment-for-side-effects-of-radiotherapy-to-the-bowel

Contact information

Dr Jervoise Andreyev
Scientific

Gastrointestinal Unit, Department of Medicine
Royal Marsden NHS Trust
Fulham Road
London
SW3 6JJ
United Kingdom

Phone +44 020 7808 2105
Email j@andreyev.demon.co.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleThe effective management of radiation-induced bowel injury: a randomised controlled trial
Study objectivesTo assess which tests can help decide the cause of these patients symptoms' whether treatments in fact improve patients' quality of life and whether these treatments can be delivered usefully by a specialist nurse.
Ethics approval(s)The Royal Marsden Research Ethics Committee (now merged with South West London REC1), 26/03/2007, ref: 07/Q0801/47
Health condition(s) or problem(s) studiedInjury, Occupational Diseases, Poisoning: Radiation
InterventionRandomised test intervention vs standardised intervention, non-blinded (Phase III).
Observational (no treatment or diagnostic intervention), Quality of Life Assessment, Qualitative Study
Intervention typeOther
Primary outcome measureImprovement in gastrointestinal symptoms
Secondary outcome measuresNot provided at time of registration
Overall study start date01/07/2007
Completion date31/07/2012

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants250 RMH participants
Total final enrolment218
Key inclusion criteriaPatients who have a life expectancy of more than 1 year and who have received radical pelvic radiotherapy with curative intent six months previously and who subsequently have developed new onset troublesome gastrointestinal symptoms
Key exclusion criteriaAdded May 2008:
1. Patient refusing to give informed consent
2. Patients deemed by their clinical oncologist to require immediate gastroenterological assessment
Date of first enrolment26/11/2007
Date of final enrolment12/12/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Royal Marsden NHS Trust
London
SW3 6JJ
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

The Royal Marsden NHS Foundation Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Plain English results 23/07/2018 29/03/2022 No Yes

Editorial Notes

29/03/2022: The following changes have been made:
1. The Cancer Research UK lay results summary has been added.
2. The total final enrolment number has been added.
22/02/2011: The overall trial end date was changed from 30/06/2010 to 31/07/2012.